WASHINGTON, Jan 18- Texas- based medical device company Orthofix International NV has admitted wrongdoing and agreed to pay more than $14 million to settle charges that it improperly booked revenue and paid off doctors in Brazil to boost sales, U.S. regulators said on Wednesday. The Securities and Exchange Commission said in a statement that Orthofix...
Jan 9- Abbott Laboratories moved to protect patients with its St. Jude heart implants against possible cyber attacks, releasing a software patch on Monday that the firm said will reduce the "extremely low" chance of them being hacked. The patch that Abbott began pushing out to patients on Monday addresses vulnerabilities that present the greatest risk to...
The FDA confirmed claims that cyber "vulnerabilities" could allow a hacker to remotely access St. Doctors and patients have been waiting for action from the FDA and St. Jude since August when short-selling firm Muddy Waters and cyber security firm MedSec Holdings claimed the implanted heart devices were riddled with potentially lethal security bugs.
Jan 9- Abbott Laboratories said on Monday it has begun releasing cyber security updates for its St. Abbott announced the updates as the U.S. Food and Drug Administration issued a Safety Communication advising patients and physicians to keep using the company's implanted cardiac devices following the updates. "The FDA conducted an assessment of the benefits...
FOOD AND DRUG ADMINISTRATION RELEASES SAFETY COMMUNICATION ON ABBOTT'S ST JUDE MEDICAL DEVICES.
TipRanks presents the top 10 stock ideas for next year from the five best-performing health-care analysts of 2016.
CNBC's Landon Dowdy looks into the cybersecurity of medical devices.
James Dinan, York Capital Management founder and CEO, shares his top stock picks, including St. Jude and Monsanto.
St. Jude has issued warnings about 400,000 of its heart defibrillators after two people died from malfunctions, NBC News reports.
Theranos and its founder Elizabeth Holmes have been sued by one of the blood-testing start-up's biggest backers, according to a WSJ report.
CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.
St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.
Check out the companies making headlines after the bell Tuesday.
HeartWare stock soared more than 90 percent on news that the company will be acquired by Medtronic.
CNBC's Diana Olick takes a look at bringing deskercise to the classroom.
Thermo Fisher Scientific said it would buy FEI for about $4.2 billion to gain access to its signature electron microscopy technology.
An invention that debuted Thursday could let you see all the spots you're missing when you brush.
A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.